Embla Medical hf — AGM Information 2021

Mar 5, 2021

ÖSSUR

Össur hf.'s Annual General Meeting 2021 - Candidates to the Board of Directors

Niels Jacobsen

Born in 1957

Member of the board of directors since the year 2005

Education

Master's degree in Business Administration from the University of Aarhus in Denmark

Board positions

KIRKBI A/S, deputy chairman

Nissens A/S, chairman

Thomas B. Thrige Foundation, chairman

ABOUT YOU Holding GmbH, deputy chairman

Additional duties related to William Demant Invest A/S:

Demant A/S, deputy chairman

Jeudan A/S, chairman

Össur hf., chairman

Vision RT Ltd., chairman

Founders A/S, chairman

Boston Holding A/S, board member

Experience

Mr. Jacobsen has broad management experience both as CEO and as chairman in major international companies, he is currently the CEO of William Demant Invest A/S. Previous positions include President & CEO of Demant A/S (formerly William Demant Holding A/S), President of Orion A/S and Vice President overseeing corporate affairs for both Atlas Danmark A/S and Thrige-Titan A/S.

Shares held in Össur

203,330 (incl. related parties). Mr. Jacobsen holds no share options in the Company

Other

Mr. Jacobsen has no interest links with the Company's main clients or competitors. Mr. Jacobsen is the CEO of William Demant Invest A/S, the Company's largest shareholder, and he is a dependent member of the Board.

Arne Boye Nielsen

Born in 1968

Member of the board of directors since the year 2009

Education

Master's degree in Business Administration from the Copenhagen Business School in Denmark

Board positions

Epos A/S (chairman)

Revenio Group Oyj (board member)

Interacoustics A/S (president)

Experience

Mr. Nielsen has spent his entire career with Demant A/S in various and expanding roles throughout the world. After working as an interim General Manager of Oticon Australia Pty Ltd. Mr. Nielsen assumed, in 1996, his current position as President of Diagnostics and Communications in Demant, which has operations worldwide.

Shares held in Össur

Mr. Nielsen neither has shares nor share options in the Company

Other

Mr. Nielsen has no interest links with the Company's main clients or competitors. Mr. Nielsen is employed by Demant A/S, whose largest shareholder is William Demant Invest A/S (the Company's largest shareholder), and he is a dependent member of the Board.

---

ÖSSUR

Össur hf.'s Annual General Meeting 2021 - Candidates to the Board of Directors

Dr. Svafa Grönfeldt

Born in 1965

Member of the board of directors since the year 2008

Education

Doctorate in Industrial Relations from the London School of Economics

Board positions

Icelandair (board member)

Origo (board member)

UNICEF Iceland (board member)

Mynto (board member)

Experience

Dr. Grönfeldt is the senior advisor to the Dean at the Massachusetts Institute of Technology SA+P, a founding member of MIT's newest innovation accelerator DesignX, and a co-founder of the MET fund, a Cambridge based seed investment fund. Previous positions include Chief Organizational Development Officer of Alvogen, President of Reykjavik University, deputy to the CEO of Actavis Group, Assistant Professor of Economics and Business Administration at the University of Iceland.

Shares held in Össur

Dr. Grönfeldt holds no shares nor share options in the Company

Other

Dr. Grönfeldt has no interest links with the Company's main clients, competitors, or major shareholders. Dr. Grönfeldt is a dependent member of the Board due to tenure.

Gudbjörg Edda Eggertsdóttir

Born in 1951

Member of the board of directors since the year 2013

Education

Master's degree (Pharm.) from Copenhagen University

Board positions

Brunnur Investment Fund (chairman)

Coripharma Holding ehf (vice chairman)

Florealis ehf. (chairman)

Orf Genetics hf. (board member)

Vistor hf. (board member)

Saga Medica ehf. (board member)

Pretium ehf. (chairman)

Experience

Previous positions include President & EVP Strategic Projects of Actavis Plc in Iceland, a global integrated specialty pharmaceutical company; Deputy CEO and EVP Third Party Sales at Actavis Group hf.; Deputy CEO, Head of R&D, Assistant Managing Director, Development Manager, Regulatory Manager and Marketing Manager at Delta hf.; and Medical Representative at Pharmaco hf. She was the President of the European Generic Medicines Association from 2011-2013.

Shares held in Össur

26,318 (incl. related parties). Ms. Eggertsdóttir holds no share options.

Other

Ms. Eggertsdóttir has no interest links with the Company's main clients or competitors. Ms. Eggertsdóttir is an independent member of the Board.

---

ÖSSUR

Össur hf.'s Annual General Meeting 2021 - Candidates to the Board of Directors

Dr. Alberto Esquenazi

Born in 1957

New candidate to the board of directors

Education

Dr. Esquenazi received his medical degree in Medicine and Surgery from Universidad Nacional Autonoma de Mexico. He completed his residency in PM&R at Temple University and a fellowship in gait analysis and prosthetic research at MossRehab. His research focuses on gait analysis, limb prosthetics, orthotics, spasticity management and robotics and technology in rehabilitation.

Board positions

Past president of the American Academy of PM&R and member of the board of AMRPA and Einstein Healthcare Network.

Experience

Alberto Esquenazi, MD, serves as the John Otto Haas Chair of the Department of Physical Medicine and Rehabilitation at MossRehab, in Philadelphia and is the Chief Medical Officer as well as Director of the Gait and Motion Analysis Laboratory and Clinical Director of the Regional Amputee Center. He is Professor of PM&R at Jefferson School of Medicine. Dr. Esquenazi has published widely and is a member of national and international professional, educational, and research societies.

Shares held in Össur

Dr. Esquenazi holds no shares nor share options in the Company.

Other

Dr. Esquenazi has no interest links with the Company's main clients, competitors or major shareholders. Dr. Esquenazi will be an independent member of the Board.